recombinant VSV-based vaccine (Integrated BioTherapeutics/University of Texas Medical Branch)

N/A

Report date: 2025/03/20 15:35:08

Base Information

Drug Namerecombinant VSV-based vaccine (Integrated BioTherapeutics/University of Texas Medical Branch)
Drug Alias NameNipah vaccine (Integrated BioTherapeutics/University of Texas Medical Branch)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHenipavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas Medical Branch
China Registration ClassN/A

Develop Information

Active CompaniesAbVacc IncUniversity Of Texas Medical Branch
Inactive CompaniesN/A
Active IndicationsHenipavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A